tiprankstipranks
MicroTech Medical (Hangzhou) Co., Ltd. Class H (HK:2235)
:2235
Hong Kong Market
2235
MicroTech Medical (Hangzhou) Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2235 full AI Analyst Report?

MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235) Ratios

0 Followers

MicroTech Medical (Hangzhou) Co., Ltd. Class H Ratios

HK:2235's free cash flow for Q4 2025 was ¥0.55. For the 2025 fiscal year, HK:2235's free cash flow was decreased by ¥ and operating cash flow was ¥0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.39 6.39 11.41 21.67 26.61
Quick Ratio
 6.11 6.11 11.11 21.22 25.79
Cash Ratio
 5.32 5.32 10.17 20.19 25.02
Solvency Ratio
 0.15 0.15 -0.31 -1.17 -0.30
Operating Cash Flow Ratio
 0.10 0.11 -0.72 -1.64 -1.32
Short-Term Operating Cash Flow Coverage
 0.31 0.35 -29.88 -34.63 0.00
Net Current Asset Value
¥ 1.52B¥ 1.52B¥ 1.73B¥ 1.93B¥ 2.09B
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.05 0.05 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.04 0.04 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.15 1.15 1.09 1.05 1.04
Debt Service Coverage Ratio
 0.17 -0.03 -25.75 -38.95 -749.63
Interest Coverage Ratio
 692.27 -45.23 -92.33 -384.02 -219.01
Debt to Market Cap
 0.03 0.03 <0.01 <0.01 0.00
Interest Debt Per Share
 0.23 0.23 0.01 0.01 <0.01
Net Debt to EBITDA
 -91.52 504.60 13.95 10.21 18.57
Profitability Margins
Gross Profit Margin
54.38%53.31%52.91%49.62%45.90%
EBIT Margin
2.40%-0.88%-38.12%-78.64%-69.34%
EBITDA Margin
2.93%-0.44%-35.12%-74.14%-63.50%
Operating Profit Margin
3.98%-0.88%-18.07%-48.43%-18.55%
Pretax Profit Margin
7.73%6.16%-18.27%-50.27%-20.19%
Net Profit Margin
7.69%6.12%-18.26%-50.34%-20.19%
Continuous Operations Profit Margin
7.69%6.12%-18.26%-50.34%-20.19%
Net Income Per EBT
99.40%99.38%99.95%100.13%100.00%
EBT Per EBIT
194.25%-697.91%101.10%103.81%108.85%
Return on Assets (ROA)
1.76%1.69%-2.94%-5.79%-1.53%
Return on Equity (ROE)
2.04%1.94%-3.20%-6.07%-1.58%
Return on Capital Employed (ROCE)
1.04%-0.28%-3.16%-5.82%-1.46%
Return on Invested Capital (ROIC)
0.99%-0.26%-3.15%-5.81%-1.45%
Return on Tangible Assets
1.78%1.71%-2.98%-5.88%-1.54%
Earnings Yield
1.49%1.37%-2.62%-5.36%-0.96%
Efficiency Ratios
Receivables Turnover
 3.52 4.26 2.91 3.38 3.51
Payables Turnover
 2.77 3.44 2.17 3.90 4.11
Inventory Turnover
 3.04 3.77 3.20 2.97 1.39
Fixed Asset Turnover
 2.39 2.89 1.69 2.45 1.66
Asset Turnover
 0.23 0.28 0.16 0.12 0.08
Working Capital Turnover Ratio
 0.32 0.39 0.19 0.12 0.08
Cash Conversion Cycle
 91.89 76.15 70.95 137.47 277.08
Days of Sales Outstanding
 103.59 85.60 125.43 108.13 104.08
Days of Inventory Outstanding
 119.88 96.77 113.94 122.85 261.78
Days of Payables Outstanding
 131.58 106.22 168.41 93.51 88.77
Operating Cycle
 223.47 182.37 239.36 230.98 365.86
Cash Flow Ratios
Operating Cash Flow Per Share
 0.07 0.08 -0.29 -0.36 -0.25
Free Cash Flow Per Share
 0.05 -0.02 -0.48 -0.43 -0.32
CapEx Per Share
 0.01 0.09 0.20 0.07 0.07
Free Cash Flow to Operating Cash Flow
 0.79 -0.19 1.69 1.19 1.28
Dividend Paid and CapEx Coverage Ratio
 4.81 0.84 -1.44 -5.33 -3.62
Capital Expenditure Coverage Ratio
 4.81 0.84 -1.45 -5.33 -3.62
Operating Cash Flow Coverage Ratio
 0.30 0.35 -28.70 -30.23 -150.17
Operating Cash Flow to Sales Ratio
 0.05 0.05 -0.35 -0.62 -0.62
Free Cash Flow Yield
0.79%-0.21%-8.46%-7.79%-3.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 67.08 73.09 -38.19 -18.67 -104.59
Price-to-Sales (P/S) Ratio
 5.28 4.47 6.98 9.40 21.12
Price-to-Book (P/B) Ratio
 1.35 1.42 1.22 1.13 1.66
Price-to-Free Cash Flow (P/FCF) Ratio
 126.39 -468.13 -11.82 -12.84 -26.67
Price-to-Operating Cash Flow Ratio
 97.84 89.89 -19.98 -15.25 -34.04
Price-to-Earnings Growth (PEG) Ratio
 0.14 -0.44 0.79 -0.07 2.72
Price-to-Fair Value
 1.35 1.42 1.22 1.13 1.66
Enterprise Value Multiple
 88.55 -514.07 -5.91 -2.46 -14.70
Enterprise Value
 1.37B 1.44B 717.68M 453.60M 1.62B
EV to EBITDA
 88.55 -514.07 -5.91 -2.46 -14.70
EV to Sales
 2.60 2.26 2.08 1.83 9.33
EV to Free Cash Flow
 62.15 -236.24 -3.52 -2.50 -11.78
EV to Operating Cash Flow
 49.23 45.36 -5.95 -2.96 -15.04
Tangible Book Value Per Share
 4.96 4.97 4.62 4.76 5.17
Shareholders’ Equity Per Share
 5.01 5.02 4.69 4.84 5.20
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 1.31 1.59 0.82 0.58 0.41
Net Income Per Share
 0.10 0.10 -0.15 -0.29 -0.08
Tax Burden
 0.99 0.99 1.00 1.00 1.00
Interest Burden
 3.22 -6.98 0.48 0.64 0.29
Research & Development to Revenue
 0.11 0.11 0.22 0.28 0.18
SG&A to Revenue
 0.40 0.42 0.44 0.06 0.24
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.69 0.81 1.91 1.22 3.07
Currency in CNY